COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 12 12 2020
medline: 5 1 2023
entrez: 11 12 2020
Statut: ppublish

Résumé

Our aim was to estimate provisional willingness to receive a coronavirus 2019 (COVID-19) vaccine, identify predictive socio-demographic factors, and, principally, determine potential causes in order to guide information provision. A non-probability online survey was conducted (24th September-17th October 2020) with 5,114 UK adults, quota sampled to match the population for age, gender, ethnicity, income, and region. The Oxford COVID-19 vaccine hesitancy scale assessed intent to take an approved vaccine. Structural equation modelling estimated explanatory factor relationships. 71.7% ( COVID-19 vaccine hesitancy is relatively evenly spread across the population. Willingness to take a vaccine is closely bound to recognition of the collective importance. Vaccine public information that highlights prosocial benefits may be especially effective. Factors such as conspiracy beliefs that foster mistrust and erode social cohesion will lower vaccine up-take.

Sections du résumé

BACKGROUND
Our aim was to estimate provisional willingness to receive a coronavirus 2019 (COVID-19) vaccine, identify predictive socio-demographic factors, and, principally, determine potential causes in order to guide information provision.
METHODS
A non-probability online survey was conducted (24th September-17th October 2020) with 5,114 UK adults, quota sampled to match the population for age, gender, ethnicity, income, and region. The Oxford COVID-19 vaccine hesitancy scale assessed intent to take an approved vaccine. Structural equation modelling estimated explanatory factor relationships.
RESULTS
71.7% (
CONCLUSIONS
COVID-19 vaccine hesitancy is relatively evenly spread across the population. Willingness to take a vaccine is closely bound to recognition of the collective importance. Vaccine public information that highlights prosocial benefits may be especially effective. Factors such as conspiracy beliefs that foster mistrust and erode social cohesion will lower vaccine up-take.

Identifiants

pubmed: 33305716
doi: 10.1017/S0033291720005188
pii: S0033291720005188
pmc: PMC7804077
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3127-3141

Subventions

Organisme : Department of Health
ID : II-C7-0117-20001
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2014-05-003
Pays : United Kingdom

Auteurs

Daniel Freeman (D)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Bao S Loe (BS)

The Psychometrics Centre, University of Cambridge, Cambridge, UK.

Andrew Chadwick (A)

Online Civic Culture Centre, Department of Communication and Media, Loughborough University, Loughborough, UK.

Cristian Vaccari (C)

Online Civic Culture Centre, Department of Communication and Media, Loughborough University, Loughborough, UK.

Felicity Waite (F)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Laina Rosebrock (L)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Lucy Jenner (L)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Ariane Petit (A)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Stephan Lewandowsky (S)

School of Psychological Science, University of Bristol, Bristol, UK.

Samantha Vanderslott (S)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Stefania Innocenti (S)

Smith School of Enterprise and the Environment, University of Oxford, Oxford, UK.

Michael Larkin (M)

Department of Psychology, Life and Health Sciences, Aston University, Birmingham, UK.

Alberto Giubilini (A)

Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.

Ly-Mee Yu (LM)

Nuffield Department of Primary Care, University of Oxford, Oxford, UK.

Helen McShane (H)

Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, UK.

Andrew J Pollard (AJ)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Sinéad Lambe (S)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH